GH Zebrafish Mutant

Growth Hormone Mutant Zebrafish Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Structure and Production

PropertyDetail
Protein TypeNon-glycosylated polypeptide chain
Length185 amino acids + N-terminal alanine addition
Molecular Mass21.18 kDa
Source OrganismEscherichia coli (recombinant expression)
Purification MethodProprietary chromatographic techniques
Physical FormLyophilized (freeze-dried) white powder
Solubility0.4% NaHCO₃ or water (pH 9)

Recombinant production in E. coli ensures scalable synthesis while retaining structural integrity critical for functional studies .

Vizzini Mutant (gh1 Premature Stop Codon)

The vizzini mutant harbors a premature stop codon in the gh1 gene, creating a loss-of-function (LOF) model. Key findings include:

  • Growth Defects: Post-feeding larvae exhibit progressive growth retardation, with adults ~30% smaller than wild-type .

  • Adiposity Increase: Enhanced subcutaneous and visceral fat accumulation, driven by adipocyte hypertrophy (enlarged lipid droplets) .

  • Developmental Decoupling: Stages of development (e.g., fin formation) occur at smaller body sizes compared to wild-type .

  • Nutrient Response: Reduced fat mobilization during caloric restriction, implicating GH in adipose tissue homeostasis .

Transgenic LHp-GH Zebrafish

A transgenic line expressing tilapia GH under a luteinizing hormone promoter (LHp-GH) demonstrates:

TraitObservation
Growth RateAccelerated somatic growth, improved feed conversion efficiency
Body ProportionsMaintained morphometric ratios despite rapid growth
Reproductive ImpactReduced gonad size and fecundity due to metabolic resource reallocation
Signaling PathwayIncreased IGF-1 expression via cross-species GH receptor binding (tilapia GH ↔ zebrafish GHr)

This model highlights GH’s role in redirecting energy allocation toward growth over reproduction .

StatMutant (GH Insensitivity Syndrome)

CRISPR-engineered stat5.1 mutants mimic human growth hormone insensitivity syndrome (GHIS):

ParameterWild-TypeStat5.1 Mutant
Adult SizeNormalSmaller (both sexes)
AdiposityNormalIncreased (females only)
Immune FunctionNormalReduced T-lymphocyte counts
GH LevelsNormalElevated (due to signaling defects)

Stat5.1 is critical for GH receptor signaling, as its truncation disrupts IGF-1 regulation and growth .

Mechanistic Insights

  • GH-IGF Axis Decoupling: In vizzini mutants, larval igf transcripts remain normal despite growth defects, suggesting GH-independent pathways in early development .

  • Adipocyte Dynamics: GH restricts hypertrophy but not adipocyte number, as shown by lipid droplet expansion in vizzini .

  • Cross-Species Relevance: Tilapia GH’s functionality in zebrafish underscores conserved GH signaling mechanisms across teleosts .

Disease Modeling

  • Short Stature: gh1 mutations model human GH deficiency, offering tools to study therapeutic interventions .

  • Obesity Research: vizzini and stat5.1 mutants provide models for adiposity linked to growth dysregulation .

  • Immunological Studies: stat5.1 mutants reveal GH’s role in hematopoiesis and lymphocyte development .

Product Specs

Introduction
Growth hormone (GH) belongs to the somatotropin/prolactin hormone family, which are key regulators of growth. The GH gene, along with four related genes, forms the growth hormone locus on chromosome 17. These genes exhibit the same transcriptional orientation, suggesting evolution through gene duplication. A high degree of sequence identity exists among these five genes. Alternative splicing further amplifies the diversity, producing various isoforms of each growth hormone, potentially leading to functional specialization. This specific family member is expressed in the pituitary gland but not in placental tissue, unlike the other four genes in the growth hormone locus. Mutations or deletions in this gene can result in growth hormone deficiency, leading to short stature.
Description
Somatotropin Zebrafish Mutant G113R Recombinant, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 185 amino acids, including an additional Alanine at the N-terminus, and has a molecular weight of 21.18 kDa. Purification of the Zebrafish Mutant G113R Recombinant is achieved using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
The protein was lyophilized from a solution with a concentration of 1 mg/ml in 0.5% NaHCO3 at a pH of 8.
Solubility
To reconstitute the lyophilized Zebrafish Mutant G113R, it is recommended to use 0.4% NaHCO3 or water adjusted to a pH of 9. The reconstitution concentration should be at least 100 µg/ml. The solution can be further diluted in other aqueous solutions. It is advisable to include a carrier protein like BSA or similar during dilution.
Stability
Lyophilized Growth Hormone remains stable at room temperature for a minimum of two weeks. However, for optimal storage, it should be kept desiccated at a temperature below -18°C. After reconstitution and sterilization by filtration, GH can be stored at 4°C for up to 4 weeks at a pH of 9. For long-term storage or when handling more diluted solutions, adding a carrier protein (0.1% HSA or BSA) is recommended. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 99.0% using the following methods: (a) Analysis by Size Exclusion Chromatography-High Performance Liquid Chromatography (SEC-HPLC). (b) Analysis by Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE).
Synonyms
GH1, GH, GHN, GH-N, hGH-N, Pituitary growth hormone, Growth hormone 1, Somatotropin.
Source
Escherichia Coli.
Amino Acid Sequence
The sequence of the first six N-terminal amino acids was determined and was found to be Ala-Gln-Arg-Leu-Phe-Asn.

Q&A

What are the primary GH zebrafish mutants used in research?

Two primary GH zebrafish mutant models are commonly used in research. The vizzini mutant contains a premature stop codon in the gh1 gene, exhibiting growth hormone deficiency . Another important model is the Stat5.1 mutant, which mimics human STAT5B loss-of-function mutations leading to growth hormone insensitivity syndrome with immune dysregulation 1 (GHISID1) . Both models demonstrate reduced somatic growth, but through different mechanisms - one through GH deficiency and the other through GH insensitivity.

How do GH zebrafish mutants differ phenotypically from wild-type zebrafish?

GH zebrafish mutants exhibit several distinct phenotypic characteristics:

  • Growth retardation: Both vizzini and Stat5.1 mutants display significantly decreased somatic growth compared to wild-type siblings, with size differences becoming increasingly pronounced with age .

  • Increased adiposity: Despite their smaller size, these mutants show enhanced adipose tissue accumulation, particularly subcutaneous and visceral adipose tissues .

  • Developmental timing: In vizzini mutants, developmental stages are attained at progressively older ages than in wild-type fish, although the order of developmental milestones remains unchanged .

  • Sex-specific differences: Female Stat5.1 mutants particularly demonstrate increased adiposity compared to their male counterparts .

When do phenotypic differences first appear in GH zebrafish mutants?

In vizzini mutants, no significant growth differences are observed during embryonic and early larval development (before 5 dpf), similar to the GH-independent growth seen during embryonic, fetal, and early postnatal periods in humans . Size differences become apparent after the onset of feeding (5 days post-fertilization) and become increasingly pronounced with age . This timing suggests that GH-dependent growth mechanisms become increasingly important during post-embryonic development.

How are GH zebrafish mutants generated?

GH zebrafish mutants are generated through various genetic approaches:

  • Chemical mutagenesis: The vizzini mutant was produced through ethyl-N-nitrosourea (ENU) mutagenesis in an inbred AB genetic background, followed by screening through early pressure gynogenesis .

  • CRISPR/Cas9 genome editing: Stat5.1 mutants were created using CRISPR/Cas9 technology with guide RNAs targeting specific exons (e.g., exon 5 and 16 of the stat5.1 gene) . After injection with gRNA and Cas9 mRNA, carriers of mutations are identified through genomic analysis, raised to adulthood, and crossed appropriately to establish stable mutant lines .

How do GH zebrafish mutants contribute to understanding human growth disorders?

GH zebrafish mutants provide valuable insights into human growth disorders through several mechanisms:

  • Modeling specific genetic conditions: The vizzini mutant (gh1 deficient) models human isolated growth hormone deficiency, while Stat5.1 mutants recapitulate human GHISID1 caused by STAT5B mutations .

  • Growth-adiposity relationship: These models demonstrate the paradoxical relationship between decreased linear growth and increased adiposity often seen in human GH disorders .

  • Developmental progression: Research with vizzini mutants shows that developmental milestones can be reached at smaller sizes and older ages, suggesting GH-independent mechanisms regulate developmental progression—an important consideration for understanding human developmental disorders .

  • Endocrine-immune interactions: Stat5.1 mutants exhibit both growth defects and immune dysregulation, allowing investigation of the interconnection between these systems as observed in human patients .

What insights do GH zebrafish mutants provide about adipose tissue development and obesity?

GH zebrafish mutants offer unique insights into adipose tissue biology:

  • Adipose hypertrophy: In vizzini mutants, subcutaneous adipose tissue (SAT) exhibits extreme enlargement of adipocyte lipid droplets without corresponding increases in lipid droplet number, suggesting GH1 signaling restricts SAT hypertrophy .

  • Precocious adipogenesis: Both subcutaneous and visceral adipose tissues undergo precocious development in GH-deficient mutants, with fat deposits greatly expanded relative to wild type at maturity .

  • Adipose tissue dynamics: Vizzini mutants show diminished SAT mobilization during caloric restriction, implicating GH1 signaling in adipose tissue homeostasis and plasticity .

  • Visualization advantages: The zebrafish system offers excellent potential for high-resolution in vivo imaging of adipose tissue, allowing non-invasive longitudinal visualization of in vivo adipose tissue formation and growth—a significant advancement over more invasive mammalian approaches .

How is gene expression affected in GH zebrafish mutants?

Gene expression profiles in GH zebrafish mutants reveal complex regulatory networks:

What immune system abnormalities are observed in GH pathway zebrafish mutants?

Immune abnormalities are particularly pronounced in Stat5.1 mutants:

  • T cell deficiency: Reduced T cell numbers are observed throughout the lifespan of Stat5.1 mutants .

  • Lymphoid compartment disruption: Broader disruption of the lymphoid compartment occurs in adulthood, including evidence of T cell activation .

  • Sex-independent immune effects: Unlike growth and adiposity phenotypes which show some sex differences, immune dysregulation affects both male and female mutants similarly .

What are the optimal methods for phenotypic characterization of GH zebrafish mutants?

Comprehensive phenotypic characterization of GH zebrafish mutants should include:

  • Growth measurements: Standard length (SL) should be measured at regular intervals from larval stages through adulthood to chart growth trajectories .

  • Developmental staging: Assessment of morphological features diagnostic for different postembryonic stages should be performed to determine if developmental milestones appear in their normal order but at different sizes/ages .

  • Adipose tissue analysis: In vivo confocal imaging of adipose tissue development provides non-invasive visualization of adipose dynamics, including lipid droplet number and size .

  • Gene expression analysis: qPCR to measure expression of GH-IGF axis genes in different tissues at multiple developmental timepoints .

  • Immune phenotyping: Flow cytometry to quantify lymphocyte populations, particularly T cells and other lymphoid lineages .

How can researchers confirm the efficacy of GH signaling rescue in zebrafish mutants?

To confirm successful rescue of GH signaling in mutant zebrafish:

  • Recombinant GH injections: Inject recombinant GH (e.g., 50 μg/g body weight) into the abdominal cavity every 2 days and measure standard length after a defined period (e.g., 9 days) .

  • Individual housing and monitoring: House fish individually in glass beakers to accurately track growth responses of individual animals .

  • Size prediction models: Use established models (e.g., quadratic polynomial regression) to predict body weight from standard length to assess growth recovery accurately .

  • Gene expression recovery: Measure recovery of downstream gene expression patterns associated with GH signaling .

What approaches should be used to study adipose tissue mobilization in GH mutants?

To effectively study adipose tissue mobilization in GH zebrafish mutants:

  • Nutrient deprivation protocols: Implement controlled caloric restriction to assess adipose tissue mobilization capacity .

  • Longitudinal imaging: Perform in vivo confocal imaging of subcutaneous adipose tissue before, during, and after nutrient deprivation to directly visualize adipose dynamics .

  • Lipid quantification: Measure changes in adipocyte lipid droplet size and number during fasting and refeeding .

  • Metabolic gene expression: Analyze expression of genes involved in lipolysis and lipogenesis during different nutritional states .

What controls are essential for interpreting GH zebrafish mutant experiments?

Critical controls for GH zebrafish mutant studies include:

  • Wild-type siblings: Using siblings from the same clutch as controls minimizes genetic background effects .

  • Heterozygous comparisons: Including heterozygous mutants can reveal potential dosage effects and dominant-negative phenotypes .

  • Age-matched controls: Given the developmental delays in mutants, comparing age-matched controls is important for distinguishing growth from developmental effects .

  • Size-matched controls: For some experiments, using size-matched rather than age-matched controls may be more appropriate to distinguish size-dependent from GH-dependent effects .

  • Sex-specific analysis: Given documented sex differences in phenotypes, males and females should be analyzed separately .

How should researchers interpret growth data from GH zebrafish mutants?

When analyzing growth data from GH zebrafish mutants:

What approaches should be used when analyzing apparently contradictory data in GH zebrafish studies?

When facing contradictory data in GH zebrafish research:

  • Developmental timing: Consider whether contradictions relate to different developmental timepoints—GH dependency increases with age, potentially explaining divergent early vs. late results .

  • Tissue specificity: Examine tissue-specific effects, as GH signaling impacts different tissues differently (e.g., Stat5.1 mutation affects liver and kidney but not muscle expression) .

  • Compensatory mechanisms: Investigate potential compensatory pathways that might mask expected phenotypes, particularly in early developmental stages .

  • Genetic background effects: Consider whether differences in genetic background contribute to phenotypic variability .

  • Methodological differences: Evaluate whether different measurement techniques or experimental conditions might explain contradictory results .

How can researchers differentiate direct vs. indirect effects of GH signaling in zebrafish mutants?

To distinguish direct from indirect effects of GH signaling:

  • Temporal analysis: Map the chronology of different phenotypes to identify primary vs. secondary effects .

  • Tissue-specific rescue: Use tissue-specific expression systems to restore GH signaling in specific tissues to determine where GH action is required for particular phenotypes .

  • Downstream pathway inhibition: Selectively inhibit specific downstream pathways (e.g., STAT5 vs. MAPK vs. PI3K) to identify which mediates particular GH effects .

  • Combined mutant analysis: Create double mutants affecting GH and potential downstream mediators to establish epistatic relationships .

  • Transcriptomic analysis: Identify direct GH target genes through acute GH stimulation coupled with transcriptomic analysis .

What are common challenges in maintaining GH zebrafish mutant lines?

Researchers face several challenges when maintaining GH zebrafish mutant lines:

  • Reproductive issues: Both male and female vizzini mutants have reproductive challenges—males produce viable sperm, but females produce only small numbers of viable eggs .

  • Growth monitoring: The significant size difference between mutants and wild-type siblings necessitates careful monitoring to prevent competition and ensure proper nutrition .

  • Genotyping accuracy: Reliable genotyping protocols must be established, particularly for mutations that don't produce obvious phenotypes until later stages .

  • Genetic background effects: Maintaining a consistent genetic background is crucial, as background mutations can modify GH-related phenotypes .

  • Health management: GH mutants may have additional health vulnerabilities requiring modified husbandry protocols .

How can researchers address potential confounding factors when studying adipose tissue in GH zebrafish mutants?

To address confounding factors in adipose tissue studies:

  • Feeding control: Implement stringent feeding protocols to ensure food intake is comparable between experimental groups, as differences could confound adiposity measurements .

  • Size normalization: Develop methods to normalize adipose measurements to body size, since mutants are significantly smaller .

  • Environmental standardization: Control temperature, light cycles, and water parameters carefully, as these factors can influence metabolism and adipose development .

  • Sex separation: Analyze males and females separately due to sex-specific differences in adiposity patterns .

  • Developmental staging: Consider developmental stage rather than just chronological age when comparing adipose depots between mutants and controls .

What methodological adaptations are needed when working with smaller GH mutant zebrafish?

Working with smaller GH mutant zebrafish requires several methodological adaptations:

  • Microinjection protocols: Adjust injection volumes and needle sizes for procedures like recombinant GH administration to account for the smaller body size .

  • Imaging parameters: Modify confocal microscopy settings to optimize visualization of structures in smaller specimens .

  • Tissue collection: Develop microdissection techniques for accurate isolation of specific tissues from smaller fish .

  • Drug dosing: Calculate drug doses based on body weight rather than using standard doses to avoid over-treatment .

  • Sample pooling: For molecular analyses requiring minimum tissue amounts, consider pooling samples from multiple mutants while ensuring appropriate statistical design .

Product Science Overview

Introduction

Growth hormone, also known as somatotropin, is a peptide hormone that plays a crucial role in regulating growth, metabolism, and reproduction in vertebrates. In zebrafish, the growth hormone gene (gh1) has been extensively studied to understand its functions and implications in various physiological processes. The creation of growth hormone mutant zebrafish using recombinant DNA technology has provided valuable insights into the roles of growth hormone in development and disease.

Creation of Growth Hormone Mutant Zebrafish

Researchers have utilized CRISPR/Cas9 technology to create zebrafish lines with mutations in the growth hormone gene (gh1). This gene editing technique allows for precise modifications in the DNA sequence, leading to the generation of mutant zebrafish with specific alterations in the growth hormone gene. These mutants serve as models to study the effects of growth hormone deficiency and its impact on various physiological processes.

Physiological Effects of Growth Hormone Mutations

Studies have shown that mutations in the growth hormone gene in zebrafish result in significant physiological changes. For instance, zebrafish with gh1 mutations exhibit dwarfism and increased adiposity . The mutants develop normally up to 14 days post-fertilization, but a high rate of mortality is observed afterward, with only a small number of mutants surviving to adulthood . The body growth of these mutants is significantly retarded in both sexes compared to their wild-type siblings .

Impact on Reproduction

Growth hormone mutations also affect reproductive functions in zebrafish. In females, the loss of the growth hormone gene arrests ovarian folliculogenesis at the primary growth stage, leading to reproductive dysfunction . Although folliculogenesis resumes after a delay, the reproductive capacity of the mutants is severely compromised. In males, the onset of spermatogenesis is delayed, and adult mutant males are unable to breed with wild-type females through natural spawning .

Metabolic Implications

The growth hormone mutant zebrafish also exhibit metabolic abnormalities. The mutants show increased accumulation of adipose tissue, with both subcutaneous and visceral fat deposits being significantly larger than those in wild-type zebrafish . This phenotype is similar to the metabolic effects observed in growth hormone-deficient mammals, where growth hormone deficiency leads to obesity and disrupted adipose tissue homeostasis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.